BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7672503)

  • 1. HLA-A associations with IDDM--a case of numbers?
    Bonifacio E
    Diabetologia; 1995 Jun; 38(6):751-2. PubMed ID: 7672503
    [No Abstract]   [Full Text] [Related]  

  • 2. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group.
    Fennessy M; Metcalfe K; Hitman GA; Niven M; Biro PA; Tuomilehto J; Tuomilehto-Wolf E
    Diabetologia; 1994 Sep; 37(9):937-44. PubMed ID: 7806025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class I HLA is associated with age-at-onset of IDDM, while class II HLA confers susceptibility to IDDM.
    Fujisawa T; Ikegami H; Kawaguchi Y; Yamato E; Takekawa K; Nakagawa Y; Hamada Y; Ueda H; Shima K; Ogihara T
    Diabetologia; 1995 Dec; 38(12):1493-5. PubMed ID: 8786033
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA and susceptibility to insulin-dependent diabetes mellitus on the island of Corsica.
    Haras D; Silicani-Amoros P; Amoros JP
    Tissue Antigens; 1994 Aug; 44(2):129-33. PubMed ID: 7817378
    [No Abstract]   [Full Text] [Related]  

  • 5. DRw9-DQw9 haplotypes and insulin-dependent diabetes mellitus in Chinese subjects.
    Penny MA; Jenkins D; Mijovic CH
    Tissue Antigens; 1991 Oct; 38(4):191. PubMed ID: 1801312
    [No Abstract]   [Full Text] [Related]  

  • 6. HLA DQ beta 3.2 identifies subtypes of DR4+ haplotypes permissive for IDDM.
    Robinson DM; Holbeck S; Palmer J; Nepom GT
    Genet Epidemiol; 1989; 6(1):149-54. PubMed ID: 2567255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leucocyte antigen and insulin gene regions and nephropathy in type I diabetes.
    Chowdhury TA; Dyer PH; Mijovic CH; Dunger DB; Barnett AH; Bain SC
    Diabetologia; 1999 Aug; 42(8):1017-20. PubMed ID: 10491764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302.
    Nejentsev S; Reijonen H; Adojaan B; Kovalchuk L; Sochnevs A; Schwartz EI; Akerblom HK; Ilonen J
    Diabetes; 1997 Nov; 46(11):1888-92. PubMed ID: 9356041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of type 1 diabetes to ancestral proportions and HLA DR/DQ alleles in a sample of the admixed Cuban population.
    Diaz-Horta O; Cintado A; Fernandez-De-Cossio ME; Nazabal M; Ferrer A; Roca J; Camacho H; Benítez J; Ale M; Villarreal A; Molina G; Vera M; Cabrera-Rode E; Novoa L
    Ann Hum Biol; 2010 Nov; 37(6):778-88. PubMed ID: 20569042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A.
    Nejentsev S; Howson JM; Walker NM; Szeszko J; Field SF; Stevens HE; Reynolds P; Hardy M; King E; Masters J; Hulme J; Maier LM; Smyth D; Bailey R; Cooper JD; Ribas G; Campbell RD; Clayton DG; Todd JA;
    Nature; 2007 Dec; 450(7171):887-92. PubMed ID: 18004301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygote advantage for HLA class-II type in hepatitis B virus infection.
    Thursz MR; Thomas HC; Greenwood BM; Hill AV
    Nat Genet; 1997 Sep; 17(1):11-2. PubMed ID: 9288086
    [No Abstract]   [Full Text] [Related]  

  • 12. [Organization of the chromosomic region of the major human histocompatibility complex].
    Vernet C; Sidibé I; Pontarotti P
    Pathol Biol (Paris); 1992 Oct; 40(8):822-30. PubMed ID: 1484743
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethnic differences in human leukocyte antigen markers of susceptibility to IDDM.
    Cruickshanks KJ; Jobim LF; Lawler-Heavner J; Neville TG; Gay EC; Chase HP; Klingensmith G; Todd JA; Hamman RF
    Diabetes Care; 1994 Feb; 17(2):132-7. PubMed ID: 8137683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of HLA DRB1, DQA1 and DQB1 alleles and susceptibility to IDDM in Chilean subjects. Chile IDDM Study Group.
    Perez-Bravo F; Serrano-Rios M; Gutierrez-Lopez MD; Calvillan M; Garcia de los Rios M; Kocova M; Dorman J; Trucco M
    Diabetologia; 1995 Mar; 38(3):378-9. PubMed ID: 7758887
    [No Abstract]   [Full Text] [Related]  

  • 15. HLA-A alleles and susceptibility to IDDM.
    Jenkins D; Mijovic C
    Diabetologia; 1995 Jun; 38(6):750-2. PubMed ID: 7672502
    [No Abstract]   [Full Text] [Related]  

  • 16. An influence of HLA-A, B, DR, DQ, and MICA on the occurrence of Celiac disease in patients with type 1 diabetes.
    Bratanic N; Smigoc Schweiger D; Mendez A; Bratina N; Battelino T; Vidan-Jeras B
    Tissue Antigens; 2010 Sep; 76(3):208-15. PubMed ID: 20492597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families.
    Chuang LM; Wu HP; Tsai WY; Lin BJ; Tai TY
    Diabetes Care; 1995 Nov; 18(11):1483-6. PubMed ID: 8722074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC microsatellite diversity and linkage disequilibrium among common HLA-A, HLA-B, DRB1 haplotypes: implications for unrelated donor hematopoietic transplantation and disease association studies.
    Malkki M; Single R; Carrington M; Thomson G; Petersdorf E
    Tissue Antigens; 2005 Aug; 66(2):114-24. PubMed ID: 16029431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DQ rather than HLA-DR region might be involved in dominant nonsusceptibility to diabetes.
    Sterkers G; Zeliszewski D; Chaussée AM; Deschamps I; Font MP; Freidel C; Hors J; Betuel H; Dausset J; Levy JP
    Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6473-7. PubMed ID: 2901099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-A, B, C, DR and DQ polymorphism in Zaireans.
    Halle L; Mbayo K; Lurhuma Z; Salmon D; Martageix C; Castellano F; Kaplan C
    Tissue Antigens; 1994 Sep; 44(3):196-9. PubMed ID: 7839354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.